[Immunopathology of chronic obstructive pulmonary disease].

Autor: Martínez-Aguilar NE; Centro Médico Coyoacán, Servicio de Pediatría, Inmunología Clínica y Alergia. Ciudad de México, México. noramar_dr@yahoo.com.mx., Vargas-Camaño ME, Hernández-Pliego RR, Chaia-Semerena GM, Pérez-Chavira MR
Jazyk: Spanish; Castilian
Zdroj: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) [Rev Alerg Mex] 2017 Jul-Sep; Vol. 64 (3), pp. 327-346.
DOI: 10.29262/ram.v64i3.263
Abstrakt: Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable condition that has a complex pathophysiology and an even more complex immunopathological process. The purpose of this review was to analyze COPD immunopathological aspects, which was addressed by undertaking a literature search for the most relevant documents indexed in the PubMed database over the last 10 years. Different conclusions could be drawn: in COPD immunopathology there are immune and non-immune inflammatory changes with oxidative stress imbalance, there are alterations in the protease/anti-protease ratio caused by direct and indirect genetic and epigenetic-environmental defects; COPD produces irreversible tissue damage and chronic inflammation with tissue repair alteration, which induces chronic obstruction of the airway, bronchitis and systemic damage. Most common resulting comorbidities include cardiovascular disease, metabolic syndrome, osteoporosis, depression, musculoskeletal dysfunction, increased biological age, lung cancer and other types of malignancies. In the conception of COPD, recognizing that it is a non-transmittable and preventable disease is indispensable.
Databáze: MEDLINE